| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Robert Jordan | Q93293800 |
| P2093 | author name string | Timothy M Block | |
| Anand S Mehta | |||
| Claus J Fimmel | |||
| P2860 | cites work | Hepatitis C and hepatocellular carcinoma | Q73717368 |
| Rising incidence of hepatocellular carcinoma in the United States | Q74595692 | ||
| Interaction between complement receptor gC1qR and hepatitis C virus core protein inhibits T-lymphocyte proliferation | Q24290542 | ||
| Hepatitis C virus core protein interacts with the cytoplasmic tail of lymphotoxin-beta receptor | Q24313170 | ||
| The NF-kappa B and I kappa B proteins: new discoveries and insights | Q24313579 | ||
| Evidence that hepatitis C virus resistance to interferon is mediated through repression of the PKR protein kinase by the nonstructural 5A protein | Q24319002 | ||
| Expression of hepatitis C virus proteins induces distinct membrane alterations including a candidate viral replication complex | Q24537657 | ||
| Hepatitis C virus subgenomic replicons induce endoplasmic reticulum stress activating an intracellular signaling pathway | Q24537844 | ||
| Insight into hepatocellular carcinogenesis at transcriptome level by comparing gene expression profiles of hepatocellular carcinoma with those of corresponding noncancerous liver | Q24555051 | ||
| Extensive oxidative DNA damage in hepatocytes of transgenic mice with chronic active hepatitis destined to develop hepatocellular carcinoma | Q24563988 | ||
| Direct interaction of hepatitis C virus core protein with the cellular lymphotoxin-beta receptor modulates the signal pathway of the lymphotoxin-beta receptor | Q24653498 | ||
| Effect of retreatment with interferon alone or interferon plus ribavirin on hepatitis C virus quasispecies diversification in nonresponder patients with chronic hepatitis C. | Q27469364 | ||
| Control of PKR protein kinase by hepatitis C virus nonstructural 5A protein: molecular mechanisms of kinase regulation | Q27469500 | ||
| Ectopic expression of hepatitis C virus core protein differentially regulates nuclear transcription factors | Q27469586 | ||
| Subcellular localization, stability, and trans-cleavage competence of the hepatitis C virus NS3-NS4A complex expressed in tetracycline-regulated cell lines | Q27469636 | ||
| Characterization of cell lines carrying self-replicating hepatitis C virus RNAs | Q27469765 | ||
| Mutations in Hepatitis C Virus RNAs Conferring Cell Culture Adaptation | Q27469769 | ||
| Assembly and Maturation of the Flavivirus Kunjin Virus Appear To Occur in the Rough Endoplasmic Reticulum and along the Secretory Pathway, Respectively | Q27469877 | ||
| Mutation of host delta9 fatty acid desaturase inhibits brome mosaic virus RNA replication between template recognition and RNA synthesis | Q27469886 | ||
| Persistent and transient replication of full-length hepatitis C virus genomes in cell culture | Q27472869 | ||
| Replication of a cytopathic strain of bovine viral diarrhea virus activates PERK and induces endoplasmic reticulum stress-mediated apoptosis of MDBK cells | Q27472902 | ||
| Insights into the Pathobiology of Hepatitis C Virus-Associated Cirrhosis | Q27478238 | ||
| Efficient initiation of HCV RNA replication in cell culture | Q27860520 | ||
| Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line | Q27860561 | ||
| Oxidants, oxidative stress and the biology of ageing | Q28131725 | ||
| Gadd153 sensitizes cells to endoplasmic reticulum stress by down-regulating Bcl2 and perturbing the cellular redox state | Q28572472 | ||
| Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis | Q29547567 | ||
| Stress signaling from the lumen of the endoplasmic reticulum: coordination of gene transcriptional and translational controls | Q29547730 | ||
| Mitogen-activated protein kinase pathways | Q29618431 | ||
| Replication of hepatitis C virus | Q29620645 | ||
| The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice | Q29620765 | ||
| The hepatitis C virus nonstructural protein 4B is an integral endoplasmic reticulum membrane protein | Q30667774 | ||
| Proteomic alterations of the variants of human aldehyde dehydrogenase isozymes correlate with hepatocellular carcinoma | Q30790833 | ||
| Oxidative DNA damage, antioxidants, and cancer | Q33638707 | ||
| Hepatitis B virus X protein is both a substrate and a potential inhibitor of the proteasome complex | Q33649039 | ||
| Pathogenesis of chronic hepatitis C: immunological features of hepatic injury and viral persistence. | Q33720363 | ||
| Quasispecies in viral persistence and pathogenesis of hepatitis C virus | Q33739366 | ||
| Double-stranded RNA-activated protein kinase mediates virus-induced apoptosis: a new role for an old actor | Q33750599 | ||
| Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury | Q33822590 | ||
| Pathogenesis, natural history, treatment, and prevention of hepatitis C. | Q33841882 | ||
| Hepatitis B virus biology | Q33855246 | ||
| Hepatitis C virus core and envelope proteins do not suppress the host's ability to clear a hepatic viral infection | Q33869825 | ||
| Identification of sequences in Brome mosaic virus replicase protein 1a that mediate association with endoplasmic reticulum membranes | Q33870474 | ||
| Hepadnavirus assembly and reverse transcription require a multi-component chaperone complex which is incorporated into nucleocapsids | Q33885913 | ||
| Human hepatitis C virus NS5A protein alters intracellular calcium levels, induces oxidative stress, and activates STAT-3 and NF-kappa B. | Q33933056 | ||
| Molecular bases for the development of hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC). | Q33998195 | ||
| Upregulation of the Golgi protein GP73 by adenovirus infection requires the E1A CtBP interaction domain | Q34152697 | ||
| How hepatitis C virus counteracts the interferon response: the jury is still out on NS5A. | Q34250843 | ||
| Management of hepatitis B: 2000--summary of a workshop | Q34263265 | ||
| Deficiencies in the acute-phase cell-mediated immune response to viral antigens are associated with development of chronic woodchuck hepatitis virus infection following neonatal inoculation | Q34330734 | ||
| Interferon-regulated pathways that control hepatitis B virus replication in transgenic mice. | Q34332959 | ||
| Structural and pathological effects of synthesis of hepatitis B virus large envelope polypeptide in transgenic mice | Q34350664 | ||
| Quantity and quality of virus-specific CD8 cell response: relevance to the design of a therapeutic vaccine for chronic HBV infection. | Q34462097 | ||
| The unfolding tale of the unfolded protein response | Q34486042 | ||
| A proteomic approach for the discovery of early detection markers of hepatocellular carcinoma | Q34493366 | ||
| Estimating the world cancer burden: Globocan 2000. | Q34518922 | ||
| Endoplasmic reticulum (ER) stress: hepatitis C virus induces an ER-nucleus signal transduction pathway and activates NF-kappaB and STAT-3. | Q34989433 | ||
| Cytokine regulation of liver development | Q34991828 | ||
| The woodchuck hepatitis virus X gene is important for establishment of virus infection in woodchucks. | Q36642780 | ||
| Cytotoxic T lymphocyte responsiveness after resolution of chronic hepatitis B virus infection | Q37353679 | ||
| Cytosol is the prime compartment of hepatitis B virus X protein where it colocalizes with the proteasome | Q39466370 | ||
| Hypermodification and immune escape of an internally deleted middle-envelope (M) protein of frequent and predominant hepatitis B virus variants | Q39505431 | ||
| Enhanced ROS production in oncogenically transformed cells potentiates c-Jun N-terminal kinase and p38 mitogen-activated protein kinase activation and sensitization to genotoxic stress | Q39528509 | ||
| Localization of pestiviral envelope proteins E(rns) and E2 at the cell surface and on isolated particles. | Q40637833 | ||
| Target disruption of the mutant beta-catenin gene in colon cancer cell line HCT116: preservation of its malignant phenotype | Q40709912 | ||
| Inhibition of host ER glucosidase activity prevents Golgi processing of virion-associated bovine viral diarrhea virus E2 glycoproteins and reduces infectivity of secreted virions | Q40729317 | ||
| Hepatitis C virus core protein enhances FADD-mediated apoptosis and suppresses TRADD signaling of tumor necrosis factor receptor | Q40808253 | ||
| Modulation of cell growth by the hepatitis C virus nonstructural protein NS5A. | Q40817254 | ||
| Identification of differentially expressed proteins between human hepatoma and normal liver cell lines by two-dimensional electrophoresis and liquid chromatography-ion trap mass spectrometry | Q40853089 | ||
| Hepatitis C virus NS5A protein protects against TNF-alpha mediated apoptotic cell death | Q40871684 | ||
| Activation of nuclear factor kappaB in hepatitis C virus infection: implications for pathogenesis and hepatocarcinogenesis | Q40895421 | ||
| The C-terminal region of the hepatitis C virus E1 glycoprotein confers localization within the endoplasmic reticulum | Q40932523 | ||
| Hepatitis B virus immunopathology | Q40951387 | ||
| Hepatitis C virus glycoprotein complex localization in the endoplasmic reticulum involves a determinant for retention and not retrieval. | Q40993767 | ||
| Frequent activation of N-myc genes by hepadnavirus insertion in woodchuck liver tumours. | Q41205751 | ||
| c-Jun N-terminal kinase is essential for growth of human T98G glioblastoma cells. | Q42488451 | ||
| Activation of mitogen-activated protein kinase by H2O2. Role in cell survival following oxidant injury | Q42816281 | ||
| The NS5A protein of hepatitis C virus partially inhibits the antiviral activity of interferon | Q42816737 | ||
| The cellular response to oxidative stress: influences of mitogen-activated protein kinase signalling pathways on cell survival | Q42828483 | ||
| Hepatitis C virus NS5A protein modulates cell cycle regulatory genes and promotes cell growth | Q42993783 | ||
| Hepatitis C virus nonstructural proteins are localized in a modified endoplasmic reticulum of cells expressing viral subgenomic replicons | Q43036635 | ||
| Epidemiology, risk factors, and natural history of hepatocellular carcinoma. | Q43038685 | ||
| Calcium signaling by HBx protein in hepatitis B virus DNA replication | Q43822550 | ||
| Expression, regulation, and function of alpha V integrins in hepatocellular carcinoma: an in vivo and in vitro study | Q44080054 | ||
| Immunohistochemistry in the differential diagnosis of liver carcinomas | Q44161726 | ||
| A strategy for the comparative analysis of serum proteomes for the discovery of biomarkers for hepatocellular carcinoma | Q44442215 | ||
| SAGE transcript profiles of normal primary human hepatocytes expressing oncogenic hepatitis B virus X protein | Q45731128 | ||
| Cutting edge: Inhibition of hepatitis B virus replication by activated NK T cells does not require inflammatory cell recruitment to the liver | Q45734530 | ||
| Identification of human cancer-related genes by naturally occurring Hepatitis B Virus DNA tagging | Q45735381 | ||
| Hepatitis B virus X protein: searching for a role in hepatocarcinogenesis | Q45742254 | ||
| Unraveling hepatitis B virus infection of mice and men (and woodchucks and ducks) | Q45746989 | ||
| Characterization of the effects of hepatitis C virus nonstructural 5A protein expression in human cell lines and on interferon-sensitive virus replication | Q45750469 | ||
| Activation of an unfolded protein response during differentiation of antibody-secreting B cells. | Q52113898 | ||
| Trends in survival of patients with hepatocellular carcinoma between 1977 and 1996 in the United States. | Q52927165 | ||
| Complex HBV populations with mutations in core promoter, C gene, and pre-S region are associated with development of cirrhosis in long-term renal transplant recipients | Q56439428 | ||
| Viral Clearance Without Destruction of Infected Cells During Acute HBV Infection | Q56951258 | ||
| Incubation phase of acute hepatitis B in man: dynamic of cellular immune mechanisms | Q57106837 | ||
| Correlation between liver iron content and magnetic resonance imaging in rats | Q69457204 | ||
| Moderate elevation of body iron level and increased risk of cancer occurrence and death | Q72788030 | ||
| P433 | issue | 33 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 5093-5107 | |
| P577 | publication date | 2003-08-01 | |
| P1433 | published in | Oncogene | Q1568657 |
| P1476 | title | Molecular viral oncology of hepatocellular carcinoma | |
| P478 | volume | 22 |
| Q35995355 | 8-Hydroxy-2'-deoxyguanosine expression predicts hepatocellular carcinoma outcome |
| Q35101845 | A comparison of statistical methods for the detection of hepatocellular carcinoma based on serum biomarkers and clinical variables |
| Q38815814 | A historical perspective on the discovery and elucidation of the hepatitis B virus |
| Q35172998 | A survey on herbal management of hepatocellular carcinoma |
| Q40809408 | Accumulation of the mutations in basal core promoter of hepatitis B virus subgenotype C1 increase the risk of hepatocellular carcinoma in Southern China |
| Q38551665 | Acetamides: chemotherapeutic agents for inflammation-associated cancers. |
| Q45208305 | Activation of activator protein 1 and extracellular signal-regulated kinases in human hepatocellular transformation |
| Q44876526 | Aflatoxin B1 and/or hepatitis B virus induced tumor spectrum in a genetically engineered hepatitis B virus expression and Trp53 haploinsufficient mouse model system for hepatocarcinogenesis |
| Q36301613 | Alpha-fetoprotein-thymidine kinase-luciferase knockin mice: a novel model for dual modality longitudinal imaging of tumorigenesis in liver |
| Q82905992 | Alterations of glycan branching and differential expression of sialic acid on alpha fetoprotein among hepatitis patients |
| Q40732977 | Altered glycosylation, expression of serum haptoglobin and alpha-1-antitrypsin in chronic hepatitis C, hepatitis C induced liver cirrhosis and hepatocellular carcinoma patients |
| Q54459996 | An intronic polymorphism in the corticotropin-releasing hormone receptor 2 gene increases susceptibility to HBV-related hepatocellular carcinoma in Chinese population. |
| Q92372287 | Anti-Tumor Effects of Vitamin B2, B6 and B9 in Promonocytic Lymphoma Cells |
| Q42176455 | Antibody Arrays Identify Potential Diagnostic Markers of Hepatocellular Carcinoma |
| Q39285212 | Antisense oligonucleotide against clusterin regulates human hepatocellular carcinoma invasion through transcriptional regulation of matrix metalloproteinase-2 and E-cadherin |
| Q26779150 | Application of CRISPR/Cas9 Technology to HBV |
| Q36845456 | Application of a novel, rapid, and sensitive oligonucleotide ligation assay for detection of cancer-predicting mutations in the precore and basal core promoter of hepatitis B virus |
| Q43058852 | Association of circulating insulin-like growth factor 1 with hepatocellular carcinoma: one cross-sectional correlation study. |
| Q44956160 | Association of human APOBEC3 cytidine deaminases with the generation of hepatitis virus B x antigen mutants and hepatocellular carcinoma |
| Q38333672 | Association of mannose-binding lectin-2 gene polymorphism with the development of hepatitis C-induced hepatocellular carcinoma |
| Q43952154 | Association of p16INK4A hypermethylation with hepatitis B virus X protein expression in the early stage of HBV-associated hepatocarcinogenesis |
| Q42246047 | Beclin 1 and nuclear factor-κBp65 are upregulated in hepatocellular carcinoma |
| Q35040709 | Branched-chain amino acids ameliorate fibrosis and suppress tumor growth in a rat model of hepatocellular carcinoma with liver cirrhosis |
| Q89313559 | Building Classification Models with Combined Biomarker Tests: Application to Early Detection of Liver Cancer |
| Q41745558 | CAHECA: computer aided hepatocellular carcinoma therapy planning |
| Q37856310 | Cancer biomarkers for hepatocellular carcinomas: from traditional markers to recent topics |
| Q38218288 | Cell cycle regulation during viral infection |
| Q39017090 | Chemopreventive and hepatoprotective effects of Epigallocatechin-gallate against hepatocellular carcinoma: role of heparan sulfate proteoglycans pathway |
| Q36104324 | Chronic hepatitis B in Korean Americans: decreased prevalence and poor linkage to care |
| Q44767670 | Chronic hepatitis B management based on standard guidelines in community primary care and specialty clinics |
| Q38538107 | Chronic hepatitis B: A wave of new therapies on the horizon |
| Q30382346 | Chronic viral hepatitis: policy, regulation, and strategies for its control and elimination in Ethiopia |
| Q47599955 | Clinical characteristics of hepatocellular carcinoma patients with normal serum alpha-fetoprotein level: A study of 112 consecutive cases. |
| Q90297652 | Clinical role of combining alpha-fetoprotein and lens culinaris agglutinin-reactive fraction of alpha-fetoprotein for hepatocellular carcinoma: Evidence from literature and an original study |
| Q50895625 | Clinicopathological significance of S100A4 expression in human hepatocellular carcinoma. |
| Q58321603 | Clusterin plays an important role in hepatocellular carcinoma metastasis |
| Q42850803 | Coagulation factor VII and malignant progression of hepatocellular carcinoma |
| Q26786180 | Common Variants of the Prostaglandin-Endoperoxide Synthase 2 Gene and Hepatocellular Carcinoma Susceptibility |
| Q89456465 | Comparison of Platelet to Lymphocyte Ratio between Degrees of the Barcelona Clinic Liver Cancer on Hepatocellular Carcinoma Patients at Haji Adam Malik General Hospital |
| Q37641583 | Comprehensive N-glycan profiles of hepatocellular carcinoma reveal association of fucosylation with tumor progression and regulation of FUT8 by microRNAs |
| Q36076440 | Construction of exogenous multiple epitopes of helper T lymphocytes and DNA immunization of its chimeric plasmid with HBV pre-S2/S gene |
| Q47220725 | Curcumin combined with glycyrrhetinic acid inhibits the development of hepatocellular carcinoma cells by down-regulating the PTEN/PI3K/AKT signalling pathway |
| Q40098739 | Cytidine deaminase APOBEC3B interacts with heterogeneous nuclear ribonucleoprotein K and suppresses hepatitis B virus expression |
| Q36139517 | Cytogenetic and molecular genetic alterations in hepatocellular carcinoma. |
| Q51582139 | Decrease in CD4+ T lymphocyte proliferation responses and enhanced CD150 cell expression in health care workers non-responsive to HBV vaccine. |
| Q28300995 | Deregulation of the NLRP3 inflammasome in hepatic parenchymal cells during liver cancer progression |
| Q40238869 | Differential effects on apoptosis induction in hepatocyte lines by stable expression of hepatitis B virus X protein |
| Q52967770 | Diminished transcription of chromosome arm 4q is inversely related to local spreading of hepatocellular carcinoma. |
| Q40549110 | Direct fluorometric measurement of hepatitis C virus helicase activity |
| Q34967879 | Downregulation of miR-610 promotes proliferation and tumorigenicity and activates Wnt/β-catenin signaling in human hepatocellular carcinoma |
| Q47372154 | Effects of Different Anesthetic Methods on Cellular Immune and Neuroendocrine Functions in Patients With Hepatocellular Carcinoma Before and After Surgery. |
| Q35194021 | Efficient induction of apoptosis by wee1 kinase inhibition in hepatocellular carcinoma cells |
| Q33819100 | Enhanced antiviral and antifibrotic effects of short hairpin RNAs targeting HBV and TGF-β in HBV-persistent mice |
| Q39098507 | Enhanced binding to and killing of hepatocellular carcinoma cells in vitro by melittin when linked with a novel targeting peptide screened from phage display |
| Q26750444 | Epidemiology of Hepatocellular Carcinoma in the Asia-Pacific Region |
| Q37834897 | Epigenetic modulation of host: new insights into immune evasion by viruses |
| Q54180290 | Epigenetically silenced long noncoding-SRHC promotes proliferation of hepatocellular carcinoma. |
| Q38212153 | Epithelial-mesenchymal transition: molecular pathways of hepatitis viruses-induced hepatocellular carcinoma progression |
| Q34721561 | Evaluation of α-fetoprotein-L3 and Golgi protein 73 detection in diagnosis of hepatocellular carcinoma |
| Q37540212 | Evolving New Strategies for the Medical Management of Chronic Hepatitis B Virus Infection |
| Q42233630 | Exportin 4 gene expression and DNA promoter methylation status in chronic hepatitis B virus infection. |
| Q45365068 | Expression and gene polymorphisms of interleukin 28B and hepatitis B virus infection in a Chinese Han population |
| Q54312067 | Expression and prognostic value of ING3 in human primary hepatocellular carcinoma. |
| Q33648955 | Extending survival with the use of targeted therapy in the treatment of hepatocellular carcinoma |
| Q34795631 | FBX8 Acts as an Invasion and Metastasis Suppressor and Correlates with Poor Survival in Hepatocellular Carcinoma |
| Q37193598 | Factor VII promotes hepatocellular carcinoma progression through ERK-TSC signaling |
| Q36497118 | Fibroblast growth factor-4 and hepatocyte growth factor induce differentiation of human umbilical cord blood-derived mesenchymal stem cells into hepatocytes |
| Q35721877 | Focus on hepatocellular carcinoma. |
| Q24624817 | Foxm1b transcription factor is essential for development of hepatocellular carcinomas and is negatively regulated by the p19ARF tumor suppressor |
| Q35048239 | Functional analysis of microRNAs in human hepatocellular cancer stem cells |
| Q27490242 | Gene profiling, biomarkers and pathways characterizing HCV-related hepatocellular carcinoma |
| Q33380441 | Genetic profile of Egyptian hepatocellular-carcinoma associated with hepatitis C virus Genotype 4 by 15 K cDNA microarray: preliminary study |
| Q80353336 | Genetics of hepatocellular carcinoma |
| Q38366329 | Glycosylation and liver cancer |
| Q36388400 | HBV induced carcinogenesis |
| Q27478342 | HBV, HCV, and TTV detection by in situ polymerase chain reaction could reveal occult infection in hepatocellular carcinoma: comparison with blood markers |
| Q34748257 | HBx modulates iron regulatory protein 1-mediated iron metabolism via reactive oxygen species. |
| Q52369573 | Hepatitis B Virus-Associated Hepatocellular Carcinoma and Hepatic Cancer Stem Cells. |
| Q40574198 | Hepatitis B virus (HBV) X protein-mediated regulation of hepatocyte metabolic pathways affects viral replication |
| Q45353493 | Hepatitis B virus X protein (HBx)-related long noncoding RNA (lncRNA) down-regulated expression by HBx (Dreh) inhibits hepatocellular carcinoma metastasis by targeting the intermediate filament protein vimentin |
| Q40399517 | Hepatitis B virus X protein represses E-cadherin expression via activation of DNA methyltransferase 1. |
| Q39907560 | Hepatitis B virus X protein sensitizes cells to starvation-induced autophagy via up-regulation of beclin 1 expression |
| Q45386179 | Hepatitis B virus X protein shifts human hepatic transforming growth factor (TGF)-beta signaling from tumor suppression to oncogenesis in early chronic hepatitis B. |
| Q27024630 | Hepatitis B virus and microRNAs: Complex interactions affecting hepatitis B virus replication and hepatitis B virus-associated diseases |
| Q34045589 | Hepatitis B virus large and middle glycoproteins are degraded by a proteasome pathway in glucosidase-inhibited cells but not in cells with functional glucosidase enzyme |
| Q36267305 | Hepatitis B virus modulates store-operated calcium entry to enhance viral replication in primary hepatocytes |
| Q28818406 | Hepatitis B virus molecular biology and pathogenesis |
| Q40234203 | Hepatitis B virus replication causes oxidative stress in HepAD38 liver cells |
| Q34012962 | Hepatitis B virus x gene and cyanobacterial toxins promote aflatoxin B1-induced hepatotumorigenesis in mice |
| Q33787553 | Hepatitis B virus-induced oncogenesis. |
| Q43658788 | Hepatitis B x-interacting protein induces HepG2 cell proliferation through activation of the phosphatidylinositol 3-kinase/Akt pathway |
| Q36561567 | Hepatitis C virus-related hepatocellular carcinoma: An insight into molecular mechanisms and therapeutic strategies |
| Q36111060 | Hepatitis status, child-pugh classification, and serum AFP levels predict survival in patients treated with transarterial embolization for unresectable hepatocellular carcinoma |
| Q92982280 | Hepatocellular Carcinoma in Asia: A Challenging Situation |
| Q42053469 | Hepatocellular Carcinoma: Past and Future of Molecular Target Therapy |
| Q29615767 | Hepatocellular carcinoma pathogenesis: from genes to environment |
| Q39307416 | Hepatocellular carcinoma treatment: a comparative review of emerging growth factor receptor antagonists |
| Q28087638 | Hepatocellular carcinoma: A comprehensive review |
| Q37888329 | Hepatocellular carcinoma: the point of view of the hepatitis B virus |
| Q36377949 | Hepatocellular carcinoma: therapy and prevention |
| Q87725770 | Hepatocyte nuclear factor 4α-nuclear factor-κB feedback circuit modulates liver cancer progression |
| Q58703392 | Host functions used by hepatitis B virus to complete its life cycle: Implications for developing host-targeting agents to treat chronic hepatitis B |
| Q37905799 | Human telomerase expression regulation |
| Q39590514 | IGFBP7 downregulation is associated with tumor progression and clinical outcome in hepatocellular carcinoma |
| Q38626350 | IL-22: a promising candidate to inhibit viral-induced liver disease progression and hepatocellular carcinoma |
| Q28579872 | Id2 leaves the chromatin of the E2F4-p130-controlled c-myc promoter during hepatocyte priming for liver regeneration |
| Q41479549 | Identification of IgM as a contaminant in lectin-FLISA assays for HCC detection |
| Q41845873 | Improved biomarker performance for the detection of hepatocellular carcinoma by inclusion of clinical parameters |
| Q36051363 | Increased levels of tetra-antennary N-linked glycan but not core fucosylation are associated with hepatocellular carcinoma tissue |
| Q43035299 | Induction of neutralizing antibody responses to hepatitis C virus with synthetic peptide constructs incorporating both antibody and T-helper epitopes |
| Q43582626 | Inflammation-induced hepatocellular carcinoma is dependent on CCR5 in mice |
| Q42248443 | Inhibition of Annexin A2 gene transcription is a promising molecular target for hepatoma cell proliferation and metastasis |
| Q38292987 | Integration of hepatitis B virus DNA into the myeloid/lymphoid or mixed-lineage leukemia (MLL4) gene and rearrangements of MLL4 in human hepatocellular carcinoma |
| Q24322868 | Interaction between nucleophosmin and HBV core protein increases HBV capsid assembly |
| Q36393694 | Interleukin-6 and oncostatin M are elevated in liver disease in conjunction with candidate hepatocellular carcinoma biomarker GP73. |
| Q40495935 | Involvement of extracellular signal-regulated kinase/mitogen-activated protein kinase pathway in multidrug resistance induced by HBx in hepatoma cell line |
| Q39474540 | Involvement of the NF-κB pathway in multidrug resistance induced by HBx in a hepatoma cell line |
| Q37818488 | Is chronic hepatitis B being undertreated in the United States? |
| Q37247425 | Is complement good or bad for cancer patients? A new perspective on an old dilemma |
| Q37621007 | Knockdown of 14-3-3ζ enhances radiosensitivity and radio-induced apoptosis in CD133(+) liver cancer stem cells |
| Q40150135 | Knowledge, Awareness, and Prevention of Hepatitis B Virus Infection Among Korean American Parents |
| Q36619028 | LINC00152 promotes proliferation in hepatocellular carcinoma by targeting EpCAM via the mTOR signaling pathway |
| Q64120609 | LINC01296 promotes proliferation, migration, and invasion of HCC cells by targeting miR-122-5P and modulating EMT activity |
| Q33682219 | Linkage specific fucosylation of alpha-1-antitrypsin in liver cirrhosis and cancer patients: implications for a biomarker of hepatocellular carcinoma |
| Q35615755 | Liver angiogenesis as a risk factor for hepatocellular carcinoma development in hepatitis C virus cirrhotic patients. |
| Q44615087 | Liver resection for hepatocellular carcinoma in patients without cirrhosis |
| Q33594868 | Liver transplantation for malignancy: current treatment strategies and future perspectives |
| Q50132449 | LncRNA-NEF antagonized epithelial to mesenchymal transition and cancer metastasis via cis-regulating FOXA2 and inactivating Wnt/β-catenin signaling. |
| Q41874511 | Long non-coding RNA CCAT2 functions as an oncogene in hepatocellular carcinoma, regulating cellular proliferation, migration and apoptosis |
| Q48008358 | Long non-coding RNA Fer-1-like protein 4 acts as a tumor suppressor via miR-106a-5p and predicts good prognosis in hepatocellular carcinoma |
| Q33798405 | Long noncoding RNA PCAT-14 induces proliferation and invasion by hepatocellular carcinoma cells by inducing methylation of miR-372. |
| Q91996515 | Long term outcome of a community-based hepatitis B awareness campaign: eight-year follow-up on linkage to care (LTC) in HBV infected individuals |
| Q35233796 | Low mir-372 expression correlates with poor prognosis and tumor metastasis in hepatocellular carcinoma |
| Q39399138 | MARVELD1 inhibited cell proliferation and enhance chemosensitivity via increasing expression of p53 and p16 in hepatocellular carcinoma |
| Q51966404 | MBL2 and MASP2 gene polymorphisms in patients with hepatocellular carcinoma. |
| Q35643898 | MEK1 expression and its relationship with clinical pathological features in hepatocellular carcinoma |
| Q34169231 | Management of hepatitis B: a longitudinal national survey - impact of the Canadian Hepatitis B Consensus Guidelines. |
| Q45423225 | Mannose-binding lectin in chronic hepatitis B virus infection |
| Q33324569 | Mass spectrometric profiling of N-linked oligosaccharides and uncommon glycoform in mouse serum with head and neck tumor |
| Q42219264 | Massive gene amplification drives paediatric hepatocellular carcinoma caused by bile salt export pump deficiency |
| Q40409352 | Measuring Changes in Cytosolic Calcium Levels in HBV- and HBx-Expressing Cultured Primary Hepatocytes |
| Q36512697 | Metallothionein expression is suppressed in primary human hepatocellular carcinomas and is mediated through inactivation of CCAAT/enhancer binding protein alpha by phosphatidylinositol 3-kinase signaling cascade |
| Q39025811 | MiR-335 acts as a potential tumor suppressor miRNA via downregulating ROCK1 expression in hepatocellular carcinoma |
| Q34294469 | MicroRNA-140 acts as a liver tumor suppressor by controlling NF-κB activity by directly targeting DNA methyltransferase 1 (Dnmt1) expression. |
| Q38163522 | MicroRNAs and liver disease: viral hepatitis, liver fibrosis and hepatocellular carcinoma |
| Q44172190 | Microvesicle microRNA profiles and functional roles between chronic hepatitis B and hepatocellular carcinoma |
| Q36616605 | Mitochondrial D-loop mutations and deletion profiles of cancerous and noncancerous liver tissue in hepatitis B virus-infected liver |
| Q33855801 | Molecular Pathogenesis of Hepatitis-B-virus-associated Hepatocellular Carcinoma |
| Q58784853 | Molecular Targets in Hepatocarcinogenesis and Implications for Therapy |
| Q33680701 | Molecular genetics of hepatocellular neoplasia. |
| Q34605680 | Molecular profiling of hepatocellular carcinomas by cDNA microarray |
| Q36618666 | Molecular signatures associated with HCV-induced hepatocellular carcinoma and liver metastasis |
| Q35541482 | Molecular targets and oxidative stress biomarkers in hepatocellular carcinoma: an overview |
| Q36282234 | Molecular virology of hepatitis B virus for clinicians |
| Q26701396 | Multi-organ Mapping of Cancer Risk |
| Q39154317 | Multitargeting and antimetastatic potentials of silibinin in human HepG-2 and PLC/PRF/5 hepatoma cells. |
| Q38098807 | Mutations in TP53, CTNNB1 and PIK3CA genes in hepatocellular carcinoma associated with hepatitis B and hepatitis C virus infections |
| Q33838472 | N-linked glycan changes of serum haptoglobin β chain in liver disease patients |
| Q38296442 | N-linked glycosylation of the liver cancer biomarker GP73 |
| Q29614598 | NF-kappaB functions as a tumour promoter in inflammation-associated cancer |
| Q35347976 | NF-κB and STAT3 - key players in liver inflammation and cancer |
| Q38359190 | NF-κB in cancer therapy. |
| Q35036844 | Novel changes in glycosylation of serum Apo-J in patients with hepatocellular carcinoma |
| Q35549677 | Novel fucosylated biomarkers for the early detection of hepatocellular carcinoma |
| Q39305166 | Nucleolar localization of human hepatitis B virus capsid protein |
| Q40226496 | Nucleoporin 88 expression in hepatitis B and C virus-related liver diseases |
| Q41950843 | Optimization of competitively differentiated polymerase chain reaction in detection of HBV basal core promoter mutation |
| Q79434802 | Overexpression of NDRG1 is an indicator of poor prognosis in hepatocellular carcinoma |
| Q28246572 | Overexpression of insulin receptor substrate-1 and hepatitis Bx genes causes premalignant alterations in the liver |
| Q37335160 | Overexpression of polo-like kinase1 predicts a poor prognosis in hepatocellular carcinoma patients |
| Q38780794 | Overexpression of the metastasis-associated gene MTA3 correlates with tumor progression and poor prognosis in hepatocellular carcinoma |
| Q41762610 | PCDH10 gene inhibits cell proliferation and induces cell apoptosis by inhibiting the PI3K/Akt signaling pathway in hepatocellular carcinoma cells |
| Q30418176 | PNPLA3 I148M associations with liver carcinogenesis in Japanese chronic hepatitis C patients |
| Q46327411 | Paracetamol: overdose-induced oxidative stress toxicity, metabolism, and protective effects of various compounds in vivo and in vitro. |
| Q38114060 | Particle platforms for cancer immunotherapy |
| Q58116467 | Pharmacological inhibition or small interfering RNA targeting acid ceramidase sensitizes hepatoma cells to chemotherapy and reduces tumor growth in vivo |
| Q37017065 | Phase I Study of Lenalidomide and Sorafenib in Patients With Advanced Hepatocellular Carcinoma |
| Q37886693 | Potential targets for molecular imaging of apoptosis resistance in hepatocellular carcinoma |
| Q47163245 | Pre-treatment alphafeto protein in hepatocellular carcinoma with non-viral aetiology - a prospective study |
| Q35020474 | Predictive power of hepatitis B 1762T/1764A mutations in plasma for hepatocellular carcinoma risk in Qidong, China |
| Q45864858 | Prognostic value of CYP2W1 expression in patients with human hepatocellular carcinoma |
| Q45366283 | Protein expression and fucosylated glycans of the serum haptoglobin-{beta} subunit in hepatitis B virus-based liver diseases |
| Q24300573 | Proteomic profiling of cellular proteins interacting with the hepatitis C virus core protein |
| Q35098035 | Quantification of complex precore mutations of hepatitis B virus by SimpleProbe real time PCR and dual melting analysis |
| Q33899239 | Quantitative proteomics reveal the anti-tumour mechanism of the carbohydrate recognition domain of Galectin-3 in Hepatocellular carcinoma |
| Q40229039 | Radiation improves antitumor effect of immune checkpoint inhibitor in murine hepatocellular carcinoma model. |
| Q37312846 | Rapid and sensitive detection of hepatitis B virus 1762T/1764A double mutation from hepatocellular carcinomas using LNA-mediated PCR clamping and hybridization probes |
| Q43506762 | Receptor for advanced glycation endproducts (RAGE) is a key regulator of oval cell activation and inflammation-associated liver carcinogenesis in mice. |
| Q37053343 | Regulation of telomerase and telomeres: human tumor viruses take control |
| Q54264663 | Relative Abundance of Integrant-Derived Viral RNAs in Infected Tissues Harvested from Chronic Hepatitis B Virus Carriers. |
| Q47564703 | Research priorities for the discovery of a cure for chronic hepatitis B: Report of a workshop. |
| Q26775650 | Risk Factors for the Development of Hepatocellular Carcinoma in Thailand |
| Q39877736 | Role of hepatitis B virus X repression of C/EBPbeta activity in the down-regulation of glutathione S-transferase A2 gene: implications in other phase II detoxifying enzyme expression |
| Q37328326 | Role of inflammation and oxidative stress mediators in gliomas |
| Q37596666 | Role of microRNAs in inflammation-associated liver cancer |
| Q38925751 | SPHK1 inhibitor suppresses cell proliferation and invasion associated with the inhibition of NF-κB pathway in hepatocellular carcinoma |
| Q90480681 | Scinderin suppresses cell proliferation and predicts the poor prognosis of hepatocellular carcinoma |
| Q90332919 | Selective cytotoxic activity and protective effects of sodium ascorbate against hepatocellular carcinoma through its effect on oxidative stress and apoptosis in vivo and in vitro |
| Q37257648 | Smad3 reduces susceptibility to hepatocarcinoma by sensitizing hepatocytes to apoptosis through downregulation of Bcl-2. |
| Q37074286 | Specific mutations of hepatitis B virus in plasma predict liver cancer development |
| Q34992624 | Superinfection with woodchuck hepatitis virus strain WHVNY of livers chronically infected with strain WHV7 |
| Q36587304 | Surrogate markers of efficacy for medical treatment of viral hepatitis. |
| Q38923977 | Targeting multiple oncogenic pathways for the treatment of hepatocellular carcinoma |
| Q36653461 | Targeting polyamines and inflammation for cancer prevention |
| Q34632966 | Targeting the PI3K/Akt/mTOR pathway in hepatocellular carcinoma. |
| Q36868580 | Telomerase as a useful target in cancer fighting-the breast cancer case |
| Q28394311 | Telomeres and telomere dynamics: relevance to cancers of the GI tract |
| Q28275462 | The AP-1 repressor protein, JDP2, potentiates hepatocellular carcinoma in mice |
| Q39640953 | The C-terminal region of the hepatitis B virus X protein is essential for its stability and function |
| Q36923172 | The Correlation Between Interferon Lambda 3 Gene Polymorphisms and Susceptibility to Hepatitis B Virus Infection. |
| Q36540674 | The Doylestown Algorithm: A Test to Improve the Performance of AFP in the Detection of Hepatocellular Carcinoma |
| Q37677914 | The Fox genes in the liver: from organogenesis to functional integration |
| Q41035560 | The Therapeutic Potential of CRISPR/Cas9 Systems in Oncogene-Addicted Cancer Types: Virally Driven Cancers as a Model System |
| Q38914193 | The aberrant expression of MEG3 regulated by UHRF1 predicts the prognosis of hepatocellular carcinoma |
| Q43497807 | The analysis of CD45 isoforms expression on HBV-specific T cells after liver transplantation |
| Q35106665 | The association of HMGB1 gene with the prognosis of HCC. |
| Q38246712 | The direct and indirect roles of HBV in liver cancer: prospective markers for HCC screening and potential therapeutic targets. |
| Q35864702 | The effects of hepatitis B virus integration into the genomes of hepatocellular carcinoma patients. |
| Q27002614 | The function of miRNA in hepatic cancer stem cell |
| Q36419017 | The molecular diagnosis of hepatitis B virus-associated hepatocellular carcinoma. |
| Q38503057 | The nucleotide binding motif of hepatitis C virus NS4B can mediate cellular transformation and tumor formation without Ha-ras co-transfection |
| Q34289586 | Three-dimensional visualization of forming Hepatitis C virus-like particles by electron-tomography |
| Q36155480 | Total serum glycan analysis is superior to lectin-FLISA for the early detection of hepatocellular carcinoma |
| Q34563492 | Transcription of the putative tumor suppressor gene HCCS1 requires binding of ETS-2 to its consensus near the transcription start site |
| Q36593582 | Transcriptome-Wide Analysis of Hepatitis B Virus-Mediated Changes to Normal Hepatocyte Gene Expression |
| Q34056196 | Transgenic expression of entire hepatitis B virus in mice induces hepatocarcinogenesis independent of chronic liver injury |
| Q34423157 | Treatment of human hepatocellular carcinoma by the oncolytic herpes simplex virus G47delta |
| Q35821161 | Two-Dimensional N-Glycan Distribution Mapping of Hepatocellular Carcinoma Tissues by MALDI-Imaging Mass Spectrometry |
| Q35140069 | Ultrasensitive quantification of hepatitis B virus A1762T/G1764A mutant by a SimpleProbe PCR using a wild-type-selective PCR blocker and a primer-blocker-probe partial-overlap approach |
| Q40359921 | Upregulation of human telomerase reverse transcriptase mRNA expression by in vitro transfection of hepatitis B virus X gene into human hepatocarcinoma and cholangiocarcinoma cells |
| Q33756008 | Use of targeted glycoproteomics to identify serum glycoproteins that correlate with liver cancer in woodchucks and humans |
| Q36814387 | Viral genotypes and associated risk factors of hepatocellular carcinoma in India |
| Q40553724 | alpha-Galactosylceramide and novel synthetic glycolipids directly induce the innate host defense pathway and have direct activity against hepatitis B and C viruses |
| Q36520310 | c-Jun N-terminal kinase inhibitor favors transforming growth factor-β to antagonize hepatitis B virus X protein-induced cell growth promotion in hepatocellular carcinoma |
| Q33592473 | miR-372 down-regulates the oncogene ATAD2 to influence hepatocellular carcinoma proliferation and metastasis |
| Q33980238 | miRNAs affect the development of hepatocellular carcinoma via dysregulation of their biogenesis and expression |
| Q42970471 | pIgR: frenemy of inflammation, EMT, and HCC progression |
Search more.